Android app on Google Play

Harvard Bioscience, Inc. (HBIO) Improves Q3 EPS to 8c Amid Lower Sales

November 1, 2012 8:59 AM EDT Send to a Friend
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q3 EPS of $0.08, versus $0.07 reported last year. Revenue for the quarter came in at $26.1 million, versus $26.4 million reported last year.

For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment